First Eagle Investment Management, LLC Precigen, Inc. Transaction History

First Eagle Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$3.5 - $6.2 $883,113 - $1.56 Million	-252,318 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$2.16 - $5.46 $1.39 Million - $3.52 Million	-644,500 Reduced 71.87%	252,318 $1.26 Million
Q1 2020 May 12, 2020	BUY	$1.46 - $7.19 $1.31 Million - $6.45 Million	896,818 New	896,818 $3.05 Million

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $331M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.